The center was established to develop and commercialize technologies aimed at improving the efficiency of detecting rearrangements in the human genome and reducing the high cost of genetic microarrays (i.e."gene chips") which are ideally suited to unraveling complex genetic information. Each of these aims to remove major technological impediments in the biotechnology and health fields. For example, the inefficient methods to detect chromosome rearrangements have hitherto limited their use in the early detection of cancer, environmental health, and population genetics, even though such rearrangements are known to provide important diagnostic information.

Biomolecular Technologies 98-99
Biomolecular Technologies 99-00

Highlights

• Two patent applications have been filed

Spin Out Companies

• GenMetrix, LLC

Benefiting Companies

Center's University Website and Contact Information